Investors place discount on Sanofi's offer
Health / Medicine Related News
Genzyme was trading at about $75, only $1 above the cash tender of the French pharmaceutical group, which has promised further cash payments as part of its $20bn takeover
Source: FT.com - Pharmaceuticals